Check these out!

 

This form does not yet contain any fields.

    wha-member

    « Heptagon Study | Main | New online service to reduce needle injuries »
    Monday
    Aug082011

    Vertex 4-drug hepatitis C combo shows promise.

    DateMonday, August 8, 2011 at 2:48PM
    CHICAGO, July 26 (Reuters) - As many as half of hepatitis C patients in a small midstage trial who received a four-drug combination, including two Vertex Pharmaceuticals <VRTX.O> medicines, were able to stop treatment after just 12 weeks, according to interim results from the study.
    Authorwebmaster | CommentPost a Comment |

    Reader Comments

    There are no comments for this journal entry. To create a new comment, use the form below.

    PostPost a New Comment

    Enter your information below to add a new comment.

    My response is on my own website »
    Author Email (optional):
    Author URL (optional):
    Post:
     
    Some HTML allowed: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>

    Notify me of follow-up comments via email.